Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

516 questions · 545 findings · 51 reviews · Gynaecology and Fertility

No studies found 129 · 23.7%GRADE not reported 5 · 0.9%Very low 196 · 36%Low 162 · 29.7%Moderate 51 · 9.4%High 2 · 0.4%

Raloxifene vs placebo

Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions

It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).

1 finding from 1 review

Raloxifene vs placebo

Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions

It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).

1 finding from 1 review

Postsurgical medical therapy vs Placebo or no active treatment

Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery

It is very uncertain whether postsurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).

1 finding from 1 review

Presurgical medical therapy vs postsurgical medical therapy

Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery

Presurgical medical therapy showed no clear difference in pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with postsurgical medical therapy (low certainty).

1 finding from 1 review

Presurgical medical therapy vs Placebo or no active treatment

Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery

It is very uncertain whether presurgical medical therapy changes pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (very low certainty).

1 finding from 1 review

Presurgical medical therapy vs Placebo or no active treatment

Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery

It is very uncertain whether presurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).

1 finding from 1 review